1. Home
  2. EVC vs VRXA Comparison

EVC vs VRXA Comparison

Compare EVC & VRXA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Entravision Communications Corporation

EVC

Entravision Communications Corporation

HOLD

Current Price

$11.59

Market Cap

335.0M

Sector

Industrials

ML Signal

HOLD

Logo Veraxa Biotech AG Ordinary Shares

VRXA

Veraxa Biotech AG Ordinary Shares

N/A

Current Price

$2.09

Market Cap

390.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
EVC
VRXA
Founded
1996
N/A
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Broadcasting
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
335.0M
390.3M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
EVC
VRXA
Price
$11.59
$2.09
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
2.1M
1.3M
Earning Date
05-05-2026
N/A
Dividend Yield
5.35%
N/A
EPS Growth
47.59
N/A
EPS
0.13
N/A
Revenue
$536,034,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$84.08
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.95
$1.70
52 Week High
$13.74
$4.50

Technical Indicators

Market Signals
Indicator
EVC
VRXA
Relative Strength Index (RSI) 55.82 27.70
Support Level $2.75 $1.88
Resistance Level $13.74 $3.49
Average True Range (ATR) 0.88 0.46
MACD -0.23 0.00
Stochastic Oscillator 28.95 21.09

Price Performance

Historical Comparison
EVC
VRXA

About EVC Entravision Communications Corporation

Entravision Communications Corp owns and operates Spanish language television and radio stations in the United States. The Company also owns and operates a smaller group of television stations that broadcast English language programming and has operations that provide programmatic advertising technology and services. The Company has organized its operations into two reportable segments. Its media segment includes its television, radio, and digital marketing operations. Its advertising and technology services segment provides programmatic advertising and technology services. The company generates the majority of its revenue from the advertising and technology services segment. Geographically, the company generates the majority of its revenue from the United States.

About VRXA Veraxa Biotech AG Ordinary Shares

Veraxa Biotech Holding AG focus on antibody therapies in medicine. The Company is an oncology-focused biotechnology Company with a clinical program in acute myeloid leukemia and two proprietary platform technologies that enable the development of new generations of antibody drug conjugates (ADC's) and T cell engagers. The Company operates in one reportable segment, focused on the research and development of products for the aging population.

Share on Social Networks: